High‐altitude headache: Insights into pathophysiology and potential treatment implications
The Journal of Physiology · 03.06.2026
DOI: 10.1113/jp289704 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Physiology, online erschienen am 03.06.2026. Verfasst von Marika Falla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
High‐altitude headache (HAH) is the most common neurological manifestation triggered by hypoxia during rapid ascent above 2500 m, often presenting as an isolated symptom or as part of acute mountain sickness (AMS). HAH shares clinical features with migraine, cluster headache and other primary headache, complicating differential diagnosis. Prevalence varies widely depending on ascent speed and altitude, with higher rates observed in populations ascending rapidly by passive transport and lower rates in those ascending gradually on foot. Controlled normobaric hypoxic chamber studies confirm hypoxia as a potent trigger, with most participants developing HAH within hours. Environmental factors, including fluctuations in barometric pressure, further contribute to headache onset. We propose that the pathophysiology involves activation and sensitization of the trigeminovascular system, with key molecular mediators such as nitric oxide, adenosine, calcitonin gene‐related peptide (CGRP) and pituitary adenylate cyclase‐activating polypeptide (PACAP) playing central roles. Hypoxia stabilizes hypoxia‐inducible factor‐1α (HIF‐1α), driving transcriptional changes that can prime vascular and neuronal pathways for head pain. Although HAH typically responds to simple analgesics and oxygen, its similarity with migraine suggests that targeted therapies against CGRP and PACAP may offer additional benefits. Future research should clarify the mechanistic continuum between HAH and AMS and evaluate multitarget therapeutic approaches. image
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.
- Center for Mind/Brain Sciences - CIMeC, University of Trento, Rovereto, Italy.
- Mountain Clinic, Eurac Research, Bolzano, Italy.
- Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Medicine - DIMED, University of Padova, Padova, Italy.
- Institute of Sport Science, Performance Physiology and Prevention, University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Marika Falla, Florian Frank, Giacomo Strapazzon, Justin Lawley
Zitieren
APA
Falla, M., Frank, F., Strapazzon, G., & Lawley, J. (2026). High‐altitude headache: Insights into pathophysiology and potential treatment implications. The Journal of Physiology. https://doi.org/10.1113/jp289704
Vancouver
Falla M, Frank F, Strapazzon G, Lawley J. High‐altitude headache: Insights into pathophysiology and potential treatment implications. The Journal of Physiology. 2026. doi:10.1113/jp289704
BibTeX
@article{Falla2026,
author = {Falla, Marika and Frank, Florian and Strapazzon, Giacomo and Lawley, Justin},
title = {High‐altitude headache: Insights into pathophysiology and potential treatment implications},
journal = {The Journal of Physiology},
year = {2026},
doi = {10.1113/jp289704}
}
EUVIMED